170
Henry JG, Sobki S, Afafat N. Interference by biotin therapy on measurement of TSH and FT4 by enzyme immunoassay on Boehringer Mannheim ES 700 analyzer. Ann Clin Biochem 1996;33:162-3.
View abstract.
171
Hochman LG, Scher RK, Meyerson MS. Brittle nails: response to daily biotin supplementation. Cutis 1993;51:303-5.
View abstract.
172
Said HM, Redha R, Nylander W. Biotin transport in the human intestine: inhibition by anticonvulsant drugs. Am J Clin Nutr 1989;49:127-31.
View abstract.
173
Bonjour JP. Biotin in human nutrition. Ann N Y Acad Sci 1985;447:97-104.
View abstract.
175
Krause KH, Bonjour JP, Berlit P, Kochen W. Biotin status of epileptics. Ann N Y Acad Sci 1985;447:297-313.
View abstract.
176
Mock DM, Mock NI, Nelson RP, Lombard KA. Disturbances in biotin metabolism in children undergoing long-term anticonvulsant therapy. J Pediatr Gastroentereol Nutr 1998;26:245-50.
View abstract.
1900
Lininger SW. The Natural Pharmacy. 1st ed. Rocklin, CA: Prima Publishing; 1998.
2677
Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams & Wilkins, 1999.
3914
Debourdeau PM, Djezzar S, Estival JL, et al. Life-threatening eosinophilic pleuropericardial effusion related to vitamins B5 and H. Ann Pharmacother 2001;35:424-6.
View abstract.
4437
Hill MJ. Intestinal flora and endogenous vitamin synthesis. Eur J Cancer Prev 1997;6:S43-5.
View abstract.
6243
Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (2000). Washington, DC: National Academy Press, 2000. Available at: http://books.nap.edu/books/0309065542/html/.
6932
Camacho FM, Garcia-Hernandez MJ. Zinc aspartate, biotin, and clobetasol propionate in the treatment of alopecia areata in childhood. Pediatr Dermatol 1999;16:336-8.
View abstract.
7878
Mock DM, Quirk JG, Mock NI. Marginal biotin deficiency during normal pregnancy. Am J Clin Nutr 2002;75:295-9.
View abstract.
7879
Zempleni J, Helm RM, Mock DM. In vivo biotin supplementation at a pharmacologic dose decreases proliferation rates of human peripheral blood mononuclear cells and cytokine release. J Nutr 2001;131:1479-84.
View abstract.
7880
Coggeshall JC, Heggers JP, Robson MC, et al. Biotin status and plasma glucose in diabetics. Ann N Y Acad Sci 1985;447:389-92.
8468
Koutsikos D, Agroyannis B, Tzanatos-Exarchou H. Biotin for diabetic peripheral neuropathy. Biomed Pharmacother 1990;44:511-4.
View abstract.
8469
Keipert JA. Oral use of biotin in seborrhoeic dermatitis of infancy: a controlled trial. Med J Aust 1976;1:584-5.
View abstract.
8501
Said HM. Biotin: the forgotten vitamin. Am J Clin Nutr. 2002;75:179-80.
View abstract.
8758
Zempleni J, Mock DM. Bioavailability of biotin given orally to humans in pharmacologic doses. Am J Clin Nutr 1999;69:504-8.
View abstract.
11579
Baez-Saldana A, Zendejas-Ruiz I, Revilla-Monsalve C, et al. Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects. Am J Clin Nutr 2004;79:238-43.
View abstract.
11593
Mock NI, Malik MI, Stumbo PJ, et al. Increased urinary excretion of 3-hydroxyisovaleric acid and decreased urinary excretion of biotin are sensitive early indicators of decreased status in experimental biotin deficiency. Am J Clin Nutr 1997;65:951-8.
View abstract.
11594
Sealey WM, Teague AM, Stratton SL, Mock DM. Smoking accelerates biotin catabolism in women. Am J Clin Nutr 2004;80:932-5.
View abstract.
11698
Krause KH, Kochen W, Berlit P, Bonjour JP. Excretion of organic acids associated with biotin deficiency in chronic anticonvulsant therapy. Int J Vitam Nutr Res 1984;54:217-22.
View abstract.
11699
Krause KH, Berlit P, Bonjour JP. Vitamin status in patients on chronic anticonvulsant therapy. Int J Vitam Nutr Res 1982;52:375-85.
View abstract.
11700
Mock DM, Dyken ME. Biotin deficiency results from long-term therapy with anticonvulsants (abstract). Gastroenterology 1995;108:A740.
12385
Geohas J, Finch M, Juturu V, et al. Improvement in Fasting Blood Glucose with the Combination of Chromium Picolinate and Biotin in Type 2 Diabetes Mellitus. American Diabetes Association 64th Annual Meeting, June 2004, Orlando, Florida, abstract 191-OR.
12390
Albarracin C, Fuqua B, Evans JL, Goldfine ID. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev 2008;24:41-51.
View abstract.
14501
Mock DM, Dyken ME. Biotin catabolism is accelerated in adults receiving long-term therapy with anticonvulsants. Neurology 1997;49:1444-7.
View abstract.
14502
Rathman SC, Eisenschenk S, McMahon RJ. The abundance and function of biotin-dependent enzymes are reduced in rats chronically administered carbamazepine. J Nutr 2002;132:3405-10.
View abstract.
15169
Singer GM, Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol Ther 2006;8:636-43.
View abstract.
15269
Ebek, Inc. issues voluntary nationwide recall of Liviro3, a product marketed as a dietary supplement. Ebek Press Release, January 19, 2007. Available at: http://www.fda.gov/oc/po/firmrecalls/ebek01_07.html.
19343
Geohas J, Daly A, Juturu V, et al. Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Am J Med Sci. 2007 Mar;333:145-53.
View abstract.
19344
Fiume MZ. Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of biotin. Int J Toxicol. 2001;20 Suppl 4:1-12.
View abstract.
19347
Roth K.S. Biotin in clinical medicine--a review. Am J Clin Nutr. 1981 Sep;34:1967-74.
View abstract.
19348
Rivera JA, González-Cossío T, Flores M, et al. Multiple micronutrient supplementation increases the growth of Mexican infants. Am J Clin Nutr. 2001 Nov;74:657-63.
View abstract.
19349
Grundy WE, Freed M, Johnson H.C., et al. The effect of phthalylsulfathiazole (sulfathalidine) on the excretion of B-vitamins by normal adults. Arch Biochem. 1947 Nov;15:187-94.
View abstract.
19350
Rodriguez-Melendez R, Griffin JB, Zempleni J. Biotin supplementation increases expression of the cytochrome P450 1B1 gene in Jurkat cells, increasing the occurrence of single-stranded DNA breaks. J Nutr. 2004 Sep;134:2222-8.
View abstract.
19352
Green NM. Avidin. 1. The use of (14-C)biotin for kinetic studies and for assay. Biochem. J. 1963;89:585-591.
View abstract.
19353
Zempleni J, Wijeratne SS, Hassan YI. Biotin. Biofactors. 2009 Jan-Feb;35:36-46.
View abstract.
19354
Spencer RP and Brody KR. Biotin transport by small intestine of rat, hamster, and other species. Am J Physiol. 1964 Mar;206:653-7.
View abstract.
19355
Eakin RE, Snell EE, and Williams RJ. Concentrationand assay of avidin, injury-producing agents in raw egg white. J Biol Chem. 1941;(40):535-43.
19356
Zempleni J, Mock DM. Biotin biochemistry and human requirements. J Nutr Biochem. 1999 Mar;10:128-38.
View abstract.
35526
Hymes, J. and Wolf, B. Human biotinidase isn't just for recycling biotin. J Nutr. 1999;129(2S Suppl):485S-489S.
View abstract.
35528
Zempleni, J. and Mock, D. M. Advanced analysis of biotin metabolites in body fluids allows a more accurate measurement of biotin bioavailability and metabolism in humans. J Nutr. 1999;129(2S Suppl):494S-497S.
View abstract.
35529
Furukawa, Y. [Enhancement of glucose-induced insulin secretion and modification of glucose metabolism by biotin]. Nippon Rinsho 1999;57(10):2261-2269.
View abstract.
35530
Narisawa, K. [Molecular basis of vitamin-responsive inborn errors of metabolism]. Nippon Rinsho 1999;57(10):2301-2306.
View abstract.
35538
Campistol, J. [Convulsions and epileptic syndromes of the newborn infant. Forms of presentation, study and treatment protocols]. Rev.Neurol. 10-1-2000;31(7):624-631.
View abstract.
35546
Snodgrass, S. R. Vitamin neurotoxicity. Mol.Neurobiol. 1992;6(1):41-73.
View abstract.
35550
Pacheco-Alvarez, D., Solorzano-Vargas, R. S., Gravel, R. A., Cervantes-Roldan, R., Velazquez, A., and Leon-Del-Rio, A. Paradoxical regulation of biotin utilization in brain and liver and implications for inherited multiple carboxylase deficiency. J Biol Chem. 12-10-2004;279(50):52312-52318.
View abstract.
35552
Baumgartner, M. R. Molecular mechanism of dominant expression in 3-methylcrotonyl-CoA carboxylase deficiency. J Inherit.Metab Dis. 2005;28(3):301-309.
View abstract.
35553
Zeng, W. Q., Al Yamani, E., Acierno, J. S., Jr., Slaugenhaupt, S., Gillis, T., MacDonald, M. E., Ozand, P. T., and Gusella, J. F. Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. Am.J Hum.Genet. 2005;77(1):16-26.
View abstract.
35556
Dakshinamurti, K. Biotin--a regulator of gene expression. J Nutr.Biochem. 2005;16(7):419-423.
View abstract.
35557
Fernandez-Mejia, C. Pharmacological effects of biotin. J Nutr.Biochem. 2005;16(7):424-427.
View abstract.
35559
Mock, D. M. Marginal biotin deficiency is teratogenic in mice and perhaps humans: a review of biotin deficiency during human pregnancy and effects of biotin deficiency on gene expression and enzyme activities in mouse dam and fetus. J Nutr.Biochem. 2005;16(7):435-437.
View abstract.
35562
Wilson, C. J., Myer, M., Darlow, B. A., Stanley, T., Thomson, G., Baumgartner, E. R., Kirby, D. M., and Thorburn, D. R. Severe holocarboxylase synthetase deficiency with incomplete biotin responsiveness resulting in antenatal insult in samoan neonates. J Pediatr. 2005;147(1):115-118.
View abstract.
35564
Prasad, A. N. and Seshia, S. S. Status epilepticus in pediatric practice: neonate to adolescent. Adv.Neurol. 2006;97:229-243.
View abstract.
35569
Bolander, F. F. Vitamins: not just for enzymes. Curr.Opin.Investig.Drugs 2006;7(10):912-915.
View abstract.
35572
Mock, D. M. Skin manifestations of biotin deficiency. Semin.Dermatol. 1991;10(4):296-302.
View abstract.
35573
Spector, R. and Johanson, C. E. Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E. J Neurochem. 2007;103(2):425-438.
View abstract.
35575
Scheinfeld, N., Dahdah, M. J., and Scher, R. Vitamins and minerals: their role in nail health and disease. J Drugs Dermatol. 2007;6(8):782-787.
View abstract.
35576
Sydenstricker, V. P., Singal, S. A., Briggs, A. P., Devaughn, N. M., and Isbell, H. PRELIMINARY OBSERVATIONS ON "EGG WHITE INJURY" IN MAN AND ITS CURE WITH A BIOTIN CONCENTRATE. Science 2-13-1942;95(2459):176-177.
View abstract.
35578
Sedel, F., Lyon-Caen, O., and Saudubray, J. M. [Treatable hereditary neuro-metabolic diseases]. Rev.Neurol.(Paris) 2007;163(10):884-896.
View abstract.
35582
Tsao, C. Y. Current trends in the treatment of infantile spasms. Neuropsychiatr.Dis.Treat. 2009;5:289-299.
View abstract.
35583
Zempleni, J., Hassan, Y. I., and Wijeratne, S. S. Biotin and biotinidase deficiency. Expert.Rev.Endocrinol.Metab 11-1-2008;3(6):715-724.
View abstract.
35586
Wolf, B. Clinical issues and frequent questions about biotinidase deficiency. Mol.Genet.Metab 2010;100(1):6-13.
View abstract.
35590
Daniells, S. and Hardy, G. Hair loss in long-term or home parenteral nutrition: are micronutrient deficiencies to blame? Curr.Opin.Clin.Nutr.Metab Care 2010;13(6):690-697.
View abstract.
35593
Colombo, V. E., Gerber, F., Bronhofer, M., and Floersheim, G. L. Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopy. J Am.Acad.Dermatol. 1990;23(6 Pt 1):1127-1132.
View abstract.
35594
Michalski, A. J., Berry, G. T., and Segal, S. Holocarboxylase synthetase deficiency: 9-year follow-up of a patient on chronic biotin therapy and a review of the literature. J Inherit.Metab Dis. 1989;12(3):312-316.
View abstract.
35595
Miller, S. J. Nutritional deficiency and the skin. J Am.Acad.Dermatol. 1989;21(1):1-30.
View abstract.
35597
Brenner, S. and Horwitz, C. Possible nutrient mediators in psoriasis and seborrheic dermatitis. II. Nutrient mediators: essential fatty acids; vitamins A, E and D; vitamins B1, B2, B6, niacin and biotin; vitamin C selenium; zinc; iron. World Rev.Nutr.Diet. 1988;55:165-182.
View abstract.
35598
Sweetman, L. and Nyhan, W. L. Inheritable biotin-treatable disorders and associated phenomena. Annu.Rev.Nutr. 1986;6:317-343.
View abstract.
35600
Nyhan, W. L. Inborn errors of biotin metabolism. Arch.Dermatol. 1987;123(12):1696-1698a.
View abstract.
35601
Magnuson, N. S. and Perryman, L. E. Metabolic defects in severe combined immunodeficiency in man and animals. Comp Biochem.Physiol B 1986;83(4):701-710.
View abstract.
35602
Bowman, B. B., Selhub, J., and Rosenberg, I. H. Intestinal absorption of biotin in the rat. J Nutr. 1986;116(7):1266-1271.
View abstract.
35604
Zlotkin, S. H., Stallings, V. A., and Pencharz, P. B. Total parenteral nutrition in children. Pediatr.Clin.North Am. 1985;32(2):381-400.
View abstract.
35605
Petrelli, F., Moretti, P., and Paparelli, M. Intracellular distribution of biotin-14COOH in rat liver. Mol.Biol.Rep. 2-15-1979;4(4):247-252.
View abstract.
35606
Ammann, A. J. New insight into the causes of immunodeficiency disorders. J Am.Acad.Dermatol. 1984;11(4 Pt 1):653-660.
View abstract.
35607
McMurray, D. N. Cell-mediated immunity in nutritional deficiency. Prog.Food Nutr.Sci 1984;8(3-4):193-228.
View abstract.
35610
Shriver, B. J., Roman-Shriver, C., and Allred, J. B. Depletion and repletion of biotinyl enzymes in liver of biotin-deficient rats: evidence of a biotin storage system. J Nutr. 1993;123(6):1140-1149.
View abstract.
35611
van der Knaap, M. S., Jakobs, C., and Valk, J. Magnetic resonance imaging in lactic acidosis. J Inherit.Metab Dis. 1996;19(4):535-547.
View abstract.
35613
Zempleni, J., McCormick, D. B., and Mock, D. M. Identification of biotin sulfone, bisnorbiotin methyl ketone, and tetranorbiotin-l-sulfoxide in human urine. Am.J Clin.Nutr. 1997;65(2):508-511.
View abstract.
35615
Zempleni, J., Green, G. M., Spannagel, A. W., and Mock, D. M. Biliary excretion of biotin and biotin metabolites is quantitatively minor in rats and pigs. J Nutr. 1997;127(8):1496-1500.
View abstract.
35616
Wallace, J. C., Jitrapakdee, S., and Chapman-Smith, A. Pyruvate carboxylase. Int J Biochem.Cell Biol. 1998;30(1):1-5.
View abstract.
35617
Ozand, P. T., Gascon, G. G., Al Essa, M., Joshi, S., Al Jishi, E., Bakheet, S., Al Watban, J., Al Kawi, M. Z., and Dabbagh, O. Biotin-responsive basal ganglia disease: a novel entity. Brain 1998;121 ( Pt 7):1267-1279.
View abstract.
35620
Sydenstricker, V. P., Singal, S. A., Briggs, A. P., Devaughn, N. M., and Isbell, H. Observations on the "egg white injury" in man and its cure with biotin concentrate. J Am Med Assn 1942;(8):199-200.
89471
Pacheco-Alvarez D, Solórzano-Vargas RS, Del Río AL. Biotin in Metabolism and Its Relationship to Human Disease. Arch Med Res 2002;33(5):439-47.
View abstract.
89472
Vadlapudi AD, Vadlapatla RK, Mitra AK. Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery. Curr Drug Targets 2012;13(7):994-1003.
View abstract.
89473
Kwok JS, Chan IH, Chan MH. Biotin interference on TSH and free thyroid hormone measurement. Pathology. 2012;44(3):278-80.
View abstract.
89474
Waghray A, Milas M, Nyalakonda K, Siperstein AE. Falsely low parathyroid hormone secondary to biotin interference: a case series. Endocr Pract 2013;19(3):451-5.
View abstract.
89475
Oguma S, Ando I, Hirose T, et al. Biotin ameliorates muscle cramps of hemodialysis patients: a prospective trial. Tohoku J Exp Med 2012;227(3):217-23.
View abstract.
94636
Minkovsky A, Lee MN, Dowlatshahi M, et al. High-dose biotin treatment for secondary progressive multiple sclerosis may interfere with thyroid assays. AACE Clin Case Rep 2016;2(4):e370-e373.
View abstract.
94637
Bülow Pedersen I, Laurberg P. Biochemical Hyperthyroidism in a Newborn Baby Caused by Assay Interaction from Biotin Intake. Eur Thyroid J 2016;5(3):212-15.
View abstract.
94638
Sulaiman RA. Biotin treatment causing erroneous immunoassay results: A word of caution for clinicians. Drug Discov Ther 2016;10(6):338-9.
View abstract.
94639
Barbesino G. Misdiagnosis of Graves' disease with apparent severe hyperthyroidism in a patient taking biotin megadoses. Thyroid 2016;26(6):860-3.
View abstract.
94640
Kummer S, Hermsen D, Distelmaier F. Biotin treatment mimicking Graves' disease. N Engl J Med 2016;375(7):704-6.
View abstract.
94641
Elston MS, Sehgal S, Du Toit S, Yarndley T, Conaglen JV. Factitious Graves' disease due to biotin immunoassay interference-a case and review of the literature. J Clin Endocrinol Metab 2016;101(9):3251-5.
View abstract.
94642
Trambas CM, Sikaris KA, Lu ZX. More on Biotin Treatment Mimicking Graves' Disease. N Engl J Med 2016;375(17):1698.
View abstract.
94649
Piketty ML, Prie D, Sedel F, et al. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference. Clin Chem Lab Med 2017;55(6):817-25.
View abstract.
94650
Biscolla RPM, Chiamolera MI, Kanashiro I, Maciel RMB, Vieira JGH. A Single 10?mg Oral Dose of Biotin Interferes with Thyroid Function Tests. Thyroid 2017;27(8):1099-1100.
View abstract.
95386
The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication. https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm586505.htm. Updated November 28, 2017. Accessed November 28, 2017.
95661
Tabarki B, Alfadhel M, AlShahwan S, Hundallah K, AlShafi S, AlHashem A. Treatment of biotin-responsive basal ganglia disease: open comparative study between the combination of biotin plus thiamine versus thiamine alone. Eur J Paediatr Neurol. 2015;19(5):547-52. doi: 10.1016/j.ejpn.2015.05.008.
View abstract.
95662
Sedel F, Papeix C, Bellanger A, Touitou V, Lebrun-Frenay C, Galanaud D, et al. High doses of biotin in chronic progressive multiple sclerosis: a pilot study.Mult Scler Relat Disord. 2015;4(2):159-69. doi: 10.1016/j.msard.2015.01.005.
View abstract.
98790
Trambas CM, Sikaris KA, Lu ZX. A caution regarding high-dose biotin therapy: misdiagnosis of hyperthyroidism in euthyroid patients. Med J Aust. 2016;205(4):192.
View abstract.
102962
Elecsys Anti-SARS-CoV-2 - Cobas. Roche Diagnostics GmbH. Available at: https://www.fda.gov/media/137605/download.
102963
Couloume L, Barbin L, Leray E, et al. High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice. Mult Scler. 2019:1352458519894713.
View abstract.
102964
Demas A, Cochin JP, Hardy C, Vaschalde Y, Bourre B, Labauge P. Tardive Reactivation of Progressive Multiple Sclerosis During Treatment with Biotin. Neurol Ther. 2019;9(1):181-185.
View abstract.
102965
Juntas-Morales R, Pageot N, Bendarraz A, et al. High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study. EClinicalMedicine. 2020;19:100254.
View abstract.
102966
Tourbah A, Lebrun-Frenay C, Edan G, et al. MD1003 (High-Dose Biotin) for the Treatment of Progressive Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Study. Mult Scler. 2016;22(13):1719-1731.
View abstract.
104000
Branger P, Parienti JJ, Derache N, Kassis N, Assouad R, Maillart E, Defer G. Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort. Neurotherapeutics. 2020.
View abstract.
104001
Kodani M, Poe A, Drobeniuc J, Mixson-Hayden T. Determination of potential biotin interference on accuracy of results of serologic assays for various viral hepatitis markers. J Med Virol.
View abstract.
104002
Li D, Ferguson A, Cervinski MA, Lynch KL, Kyle PB. AACC Guidance Document on Biotin Interference in Laboratory Tests. J Appl Lab Med. 2020;5(3):575-587.
View abstract.
104011
Cree BAC, Cutter G, Wolinsky JS, et al. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2020.
105716
Mathais S, Moisset X, Pereira B, et al. Relapses in patients treated with high-dose biotin for progressive multiple sclerosis. Neurotherapeutics. 2020 Sep 22.
View abstract.
105717
Garbers LEFM, Miola AC, Dias PCR, Miot LDB, Miot HA, Schmitt JV. Efficacy of 2.5 mg oral biotin versus 5% topical minoxidil in increasing nail growth rate. Exp Dermatol. 2021 Mar 4.
View abstract.
109534
Scheib N, Bauersachs D, Pogorelov D, et al. Biotin interference can cause false-negative specific IgE results in patients with anaphylaxis. J Allergy Clin Immunol Pract. 2022;10(9):2459-2462.e2.
View abstract.
110044
Zhang Y, Ding Y, Fan Y, et al. Influence of biotin intervention on glycemic control and lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Front Nutr 2022;9:1046800.
View abstract.
111365
Takahashi N, Shoji H, Arai H, et al. Effect of biotin supplementation in infant formula: A multi-center study in Japan. Pediatr Int 2023;65(1):e15359.
View abstract.
111366
Samadi A, Ketabi Y, Firooz R, Firooz A. Efficacy of intramuscular injections of biotin and dexpanthenol in the treatment of diffuse hair loss: A randomized, double-blind controlled study comparing two brands. Dermatol Ther. 2022;35(9):e15695.
View abstract.
112038
Shimmaru K, Inami M, Hamaoka A, et al. Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report. Endocr J 2023;70(8):833-837.
View abstract.
112039
James A, Stalan J, Kuzhively J. Biotin induced biochemical hyperthyroidism: a case report and review of the literature. J Med Case Rep 2023;17(1):266.
View abstract.